By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
ABGs are tests that specifically analyse blood that has been drawn from an artery. The partial pressure of oxygen (PaO2) and carbon dioxide in a patient are evaluated by an ABG assay (PaCO2). PaCO2 supplies information on the ventilation status, whereas PaO2 provides information on the oxygenation status (chronic or acute respiratory failure).
Hyperventilation (rapid or deep breathing), Hypoventilation (slow or shallow breathing), and Acid-Base Status all have an impact on PaCO2. Although pulse oximetry and end-tidal carbon dioxide monitoring provide for non-invasive evaluation of oxygenation and ventilation, respectively, ABG analysis is the gold standard.
The Global Arterial Blood Gas (ABG) Analyzer market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Roche has launched a new digital arterial blood gas solution intended to enhance patient care. With the use of a new digital diagnostics tool called Roche v-TAC, practitioners may now acquire arterial blood gas values from patients who require blood gas testing using a less complicated, uncomfortable, and invasive venous approach. Blood gas analysis is frequently utilised in hospital point-of-care (POC) settings where prompt and precise results are required.
This covers operating rooms, intensive care units, and emergency rooms. In order to diagnose, treat, and track a patient’s progress, clinicians need to know about their patient’s pulmonary function and acid-base status, both of which are revealed by the analysis.
The collection of an arterial blood sample, which is necessary for a standard blood gas test, can be uncomfortable for the patient because arteries often lie deeper in the tissue than veins and have a thicker wall that needs to be punctured.
Medical professionals or workers with specialised training typically perform this treatment. Staff who lack the specialised training needed to draw arterial blood samples can now do so using the Roche v-TAC digital solution by drawing venous blood samples instead, which allows them to digitally convert the results into arterial blood gas values.
This can free up specialised healthcare staff for other tasks. For usage with Roche’s cobas b 123 POC and cobas b 221 systems using the Roche cobas infinite POC solution, v-TAC is completely integrated.
